Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Tang

Showing results (1441-1450 of 1,689) with videos related to

Pageof 169
Sort By:
Clinical Science (London, England : 1979)|October 20, 2020
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosisSarah W Y Lok, Wai Han Yiu, Hongyu Li, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2025
Urinary Albumin-to-Creatinine Ratio, Cardiovascular Health, and All-Cause Mortality in Hypertension: A Nationwide Cohort AnalysisDingding Wang, Meng Zhang, Peichen Xie, et al.
Kidney International|September 1, 2023
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney diseaseKam Wa Chan, J David Smeijer, Meir Schechter, et al.
BMC Medical Informatics and Decision Making|December 8, 2020
Development of a data-driven COVID-19 prognostication tool to inform triage and step-down care for hospitalised patients in Hong Kong: a population-based cohort studyEva L H Tsui, Carrie S M Lui, Pauline P S Woo, et al.
Molecular Therapy. Nucleic Acids|December 2, 2021
Tubule-specific deletion of <i>LincRNA-p21</i>ameliorates lipotoxic kidney injuryBin Li, Joseph C K Leung, Loretta Y Y Chan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 4, 2021
[Clinical and prognostic values of TP53 mutation in patients with B-lineage acute lymphoblastic leukemia]Y Y Du, K K Lyu, M M Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 21, 2019
[Comparison of haploidentical hematopoietic stem cell transplantation and matched-sibling donor transplantation for the treatment of paroxysmal nocturnal hemoglobinuria]L M Liu, H F Zhou, Q Y Wang, et al.
Oncogenesis|November 29, 2016
FOXK1 interaction with FHL2 promotes proliferation, invasion and metastasis in colorectal cancerM Wu, J Wang, W Tang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria compared to paroxysmal nocturnal hemoglobinuria-aplastic anemia syndrome]L M Liu, H F Zhou, Q Y Wang, et al.
Cancer Research Communications|July 9, 2025
Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian CancerYa-Yun Cheng, Beth L Worley, Zaineb Javed, et al.
Pageof 169

Showing results (1441-1450 of 1,689) with videos related to

Sort By:
Pageof 169
Clinical Science (London, England : 1979)|October 20, 2020
The PAR-1 antagonist vorapaxar ameliorates kidney injury and tubulointerstitial fibrosisSarah W Y Lok, Wai Han Yiu, Hongyu Li, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 7, 2025
Urinary Albumin-to-Creatinine Ratio, Cardiovascular Health, and All-Cause Mortality in Hypertension: A Nationwide Cohort AnalysisDingding Wang, Meng Zhang, Peichen Xie, et al.
Kidney International|September 1, 2023
Post hoc analysis of the SONAR trial indicates that the endothelin receptor antagonist atrasentan is associated with less pain in patients with type 2 diabetes and chronic kidney diseaseKam Wa Chan, J David Smeijer, Meir Schechter, et al.
BMC Medical Informatics and Decision Making|December 8, 2020
Development of a data-driven COVID-19 prognostication tool to inform triage and step-down care for hospitalised patients in Hong Kong: a population-based cohort studyEva L H Tsui, Carrie S M Lui, Pauline P S Woo, et al.
Molecular Therapy. Nucleic Acids|December 2, 2021
Tubule-specific deletion of <i>LincRNA-p21</i>ameliorates lipotoxic kidney injuryBin Li, Joseph C K Leung, Loretta Y Y Chan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 4, 2021
[Clinical and prognostic values of TP53 mutation in patients with B-lineage acute lymphoblastic leukemia]Y Y Du, K K Lyu, M M Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 21, 2019
[Comparison of haploidentical hematopoietic stem cell transplantation and matched-sibling donor transplantation for the treatment of paroxysmal nocturnal hemoglobinuria]L M Liu, H F Zhou, Q Y Wang, et al.
Oncogenesis|November 29, 2016
FOXK1 interaction with FHL2 promotes proliferation, invasion and metastasis in colorectal cancerM Wu, J Wang, W Tang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Outcomes of allogeneic hematopoietic stem cell transplantation in patients with paroxysmal nocturnal hemoglobinuria compared to paroxysmal nocturnal hemoglobinuria-aplastic anemia syndrome]L M Liu, H F Zhou, Q Y Wang, et al.
Cancer Research Communications|July 9, 2025
Loss of Predicted Cell Adhesion Molecule MPZL3 Promotes EMT in Ovarian CancerYa-Yun Cheng, Beth L Worley, Zaineb Javed, et al.
Pageof 169